Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Sale of 2,593 MAZE shares, $70.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 2,593 | $70.1K |
| Sep 4, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 9,852 | $259.9K |
| Sep 3, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 2,593 | $68.2K |
| Aug 5, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 2,439 | $65.2K |
| Jul 2, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 2,593 | $77.7K |
| Jun 24, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 1,953 | $50.8K |
| Jun 3, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 6,090 | $159.5K |
| May 27, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 4,504 | $117.1K |
| May 18, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 1,822 | $47.4K |
| Mar 3, 2026 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 150,000 | n/a |